Orange Book product · Generic (ANDA)
PEMOLINE
PEMOLINE
At a glance
Feb 22, 2000
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Feb 22, 2000
26 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
PEMOLINE
Strength
18.75MG
Dosage form
TABLET
Route
ORAL
TE code
Not listed
Application
ANDA 075030
Product number
003
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PEMOLINE
- —CYLERTBrand (NDA)
NDA 017703 · ABBOTT
- —CYLERTBrand (NDA)
NDA 016832 · ABBOTT
- 2001PEMOLINEGeneric (ANDA)
ANDA 075287 · WATSON LABS
- 2001PEMOLINEGeneric (ANDA)
ANDA 075726 · MALLINCKRODT
- 2000PEMOLINEGeneric (ANDA)
ANDA 075678 · ACTAVIS ELIZABETH
- 2000PEMOLINEGeneric (ANDA)
ANDA 075328 · VINTAGE PHARMS
- 2000PEMOLINEGeneric (ANDA)
ANDA 075595 · ACTAVIS ELIZABETH
- 2000PEMOLINEGeneric (ANDA)
ANDA 075555 · TEVA PHARMS
- 1999PEMOLINEGeneric (ANDA)
ANDA 075286 · FOSUN PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
